Skip to main content
Equibles
HIMS logo

HIMS · Hims & Hers Health, Inc.

Track HIMS — free

Use HIMS with AI

Ask our own analyst here, or connect this data to the AI you already use.

Ask ALVIS about HIMS

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$28.15 -0.62 (-2.16%) At close · Aug 14
Customer concentration — top customer 10% of receivables

One customer — 10% of receivables (As of December 31, 2025)

“As of December 31, 2025, one customer or partner individually represented more than 10% of accounts receivable.”
View the 10-K filed Feb 23, 2026
Market Cap
$6.57B
Shares
233.31M

Hims & Hers Health, Inc. Earnings Call Transcripts

Every quarterly earnings call for Hims & Hers Health, Inc. (HIMS) — the full transcript with speaker labels, the audio replay, AI call highlights and a management-tone score, plus the matching 8-K earnings release and the quarter's 10-Q or 10-K. Investor days and conferences appear here too.

Revenue & result across quarters

Revenue Net income YoY up YoY down artefacts
▲95.3% $144.84M −$18.84M '22 Q3 22-11-07 ▲97.4% $167.20M −$10.91M '22 Q4 23-02-27 ▲88.3% $190.77M −$10.07M '23 Q1 23-05-08 ▲83.1% $207.91M −$7.16M '23 Q2 23-08-07 ▲56.5% $226.70M −$7.57M '23 Q3 23-11-06 ▲47.5% $246.62M $1.25M '23 Q4 24-02-26 ▲45.8% $278.17M $11.13M '24 Q1 24-05-06 ▲51.8% $315.65M $13.30M '24 Q2 24-08-05 ▲77.1% $401.56M $75.59M '24 Q3 24-11-04 ▲95.1% $481.14M $26.02M '24 Q4 25-02-24 ▲110.7% $586.01M $49.48M '25 Q1 25-05-05 ▲72.6% $544.83M $42.51M '25 Q2 25-08-04 ▲49.2% $598.98M $15.77M '25 Q3 25-11-03 ▲28.4% $617.82M $20.60M '25 Q4 26-02-23 ▲3.8% $608.10M −$92.11M '26 Q1 26-05-11 LATEST ▲38.2% $753.21M −$86.29M '26 Q2 26-08-10
Earnings call
FY26 · Q2
2026-08-10
Hims & Hers Second Quarter 2026 Earnings Call
Confident tone AI and technology platform International expansion / Eucalyptus Weight loss category (Hers)
Revenue
$753.21M
▲ 38.2% YoY
Diluted EPS
$-0.37
▼ 317.6% YoY
Gross margin
63.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Conference
Investor event
2026-06-02
2026 Evercore TMT Global Conference
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY26 · Q1
2026-05-11
Hims & Hers Health, Inc. Q1 FY2026 Earnings Call
Confident tone Data, technology and platform network effects Capital allocation discipline / free cash flow Weight loss / GLP-1 strategy
Revenue
$608.10M
▲ 3.8% YoY
Diluted EPS
$-0.40
▼ 300% YoY
Gross margin
65.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q4
2026-02-23
Hims & Hers Health, Inc. Q4 FY2025 Earnings Call
Confident tone GLP-1 and weight loss offering International expansion and M&A Platform diversification and new specialties
Revenue
$617.82M*
▲ 28.4% YoY
Gross margin
71.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY25 · Q3
2025-11-03
Hims & Hers Health, Inc. Q3 FY2025 Earnings Call
Confident tone Personalized care and platform expansion Weight loss / GLP-1 Financial outlook and 2030 targets
Revenue
$598.98M
▲ 49.2% YoY
Diluted EPS
$0.06
▼ 81.2% YoY
Gross margin
73.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2025-08-04
Hims & Hers Health, Inc. Q2 FY2025 Earnings Call
Confident tone Weight loss / GLP-1 retention results Capital allocation and marketing payback Lab testing / longevity vertical integration
Revenue
$544.83M
▲ 72.6% YoY
Diluted EPS
$0.17
▲ 183.3% YoY
Gross margin
76.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2025-05-05
Hims & Hers Health, Inc. Q1 FY2025 Earnings Call
Confident tone Weight loss / GLP-1 offerings Cash-pay model vs. insurance Long-term growth targets (2030)
Revenue
$586.01M
▲ 110.7% YoY
Diluted EPS
$0.20
▲ 300% YoY
Gross margin
73.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q4
2025-02-24
Hims & Hers Health, Inc. Q4 FY2024 Earnings Call
Confident tone GLP-1 / Weight Loss Business Women's Health (Hers Brand) Whole Body Lab Testing Acquisition
Revenue
$481.14M*
▲ 95.1% YoY
Gross margin
76.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q3
2024-11-04
Hims & Hers Health, Inc. Q3 FY2024 Earnings Call
Confident tone Personalized solutions and platform capabilities GLP-1 / Weight loss business Provider experience and adherence / retention
Revenue
$401.56M
▲ 77.1% YoY
Diluted EPS
$0.32
Gross margin
79.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q2
2024-08-05
Hims & Hers Health, Inc. Q2 FY2024 Earnings Call
Confident tone Weight management / GLP-1 launch Personalized solutions & platform expansion Subscriber growth and financial performance
Revenue
$315.65M
▲ 51.8% YoY
Diluted EPS
$0.06
Gross margin
81.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2024-05-06
Hims & Hers Health, Inc. Q1 FY2024 Earnings Call
Confident tone Personalized solutions platform Financial performance and guidance Weight loss / GLP-1
Revenue
$278.17M
▲ 45.8% YoY
Diluted EPS
$0.05
Gross margin
82.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2024-02-26
Hims & Hers Health, Inc. Q4 FY2023 Earnings Call
Confident tone Revenue and subscriber growth Affiliated pharmacies and cost Core specialties expansion
Revenue
$246.62M*
▲ 47.5% YoY
Gross margin
82.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q3
2023-11-06
Hims & Hers Health, Inc. Q3 FY2023 Earnings Call
Revenue
$226.70M
▲ 56.5% YoY
Diluted EPS
$-0.04
Gross margin
82.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q2
2023-08-07
Hims & Hers Health, Inc. Q2 FY2023 Earnings Call
Revenue
$207.91M
▲ 83.1% YoY
Diluted EPS
$-0.03
Gross margin
81.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q1
2023-05-08
Hims & Hers Health, Inc. Q1 FY2023 Earnings Call
Revenue
$190.77M
▲ 88.3% YoY
Diluted EPS
$-0.05
Gross margin
80.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2023-02-27
Hims & Hers Health, Inc. Q4 FY2022 Earnings Call
Revenue
$167.20M*
▲ 97.4% YoY
Gross margin
79.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q3
2022-11-07
Hims & Hers Health, Inc. Q3 FY2022 Earnings Call
Revenue
$144.84M
▲ 95.3% YoY
Diluted EPS
$-0.09
Gross margin
79.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q2
2022-08-08
Hims & Hers Health, Inc. Q2 FY2022 Earnings Call
Revenue
$113.56M
▲ 87.1% YoY
Diluted EPS
$-0.10
Gross margin
76.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q1
2022-05-09
Hims & Hers Health, Inc. Q1 FY2022 Earnings Call
Revenue
$101.31M
▲ 93.7% YoY
Diluted EPS
$-0.08
Gross margin
73.8%
Rev · 7q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q4
2022-02-22
Hims & Hers Health, Inc. Q4 FY2021 Earnings Call
Revenue
$84.70M*
▲ 104.3% YoY
Gross margin
73.3%
Rev · 6q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY21 · Q3
2021-11-10
Hims & Hers Health, Inc. Q3 FY2021 Earnings Call
Revenue
$74.17M
▲ 79.5% YoY
Diluted EPS
$-0.08
Gross margin
74.0%
Rev · 6q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q2
2021-08-11
Hims & Hers Health, Inc. Q2 FY2021 Earnings Call
Revenue
$60.69M
▲ 69% YoY
Diluted EPS
$-0.05
Gross margin
77.9%
Rev · 5q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q1
2021-05-18
Hims & Hers Health, Inc. Q1 FY2021 Earnings Call
Revenue
$52.31M
▲ 74% YoY
Diluted EPS
$-0.34
Gross margin
76.9%
Rev · 4q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q4
2021-03-18
Hims & Hers Health, Inc. Q4 FY2020 Earnings Call
Revenue
$41.47M*
Gross margin
76.9%
Rev · 3q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Showing 1–24 of 24 earnings calls
Key facts CIK 1773751 CUSIP 433000106 13F (30d) 485 filings 479 filers Visit website Investor relations

Report a Problem

Category
Description
Email (optional, for follow-up)